Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy
-
- Christopher M. DeGiorgio
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Jason Soss
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Ian A. Cook
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Daniela Markovic
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Jeffrey Gornbein
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Diana Murray
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Sandra Oviedo
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Steven Gordon
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Guadalupe Corralle-Leyva
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Colin P. Kealey
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
-
- Christi N. Heck
- From the Departments of Neurology (C.M.D., J.S., D.M., S.G.), Psychiatry and Biobehavioral Sciences (I.A.C.), and Biomathematics-SPCC (D.M., J.G.), David Geffen School of Medicine at UCLA; Department of Neurology (S.O., G.C.-L., C.N.H.), Keck-USC School of Medicine; and NeuroSigma, Inc. (C.P.K.), Los Angeles, CA.
書誌事項
- 公開日
- 2013-02-26
- DOI
-
- 10.1212/wnl.0b013e318285c11a
- 公開者
- Ovid Technologies (Wolters Kluwer Health)
この論文をさがす
収録刊行物
-
- Neurology
-
Neurology 80 (9), 786-791, 2013-02-26
Ovid Technologies (Wolters Kluwer Health)